Skip to content

Lifestyle Interventions for Seniors With Apnea

Effects of Weight Loss Through Diet and Exercise on Sleep Apnea Severity and Cardiovascular Risk in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01422863
Enrollment
18
Registered
2011-08-24
Start date
2010-10-31
Completion date
2012-07-31
Last updated
2017-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

weight loss, exercise, diet, sleep apnea, aging

Brief summary

The overall goal of this study is to determine the efficacy of a lifestyle intervention, consisting of a weight loss diet and exercise on sleep apnea in older adults. The investigators will conduct a 3-month intervention in men and women who are sedentary with suspected sleep apnea. The investigators hypothesize that the intervention will lead to marked improvements in sleep apnea severity and cardiovascular risk markers.

Detailed description

Frailty, a condition characterized by a decrease in physiological reserve and increased risk for adverse health-related outcomes, is an increased risk of aging, especially in the presence of co-morbid conditions. Sleep apnea is also highly prevalent with increasing age. Both conditions share common pathologies, suggesting that sleep apnea may increase the risk of developing or exacerbate the consequences of frailty. Lifestyle interventions as strategies for treating sleep apnea and associated co-morbidities, thereby highlighting a feasible approach by which to reduce the incidence or progression of frailty. The specific aims of this study are to: 1) determine the effectiveness of a lifestyle intervention (LI), consisting of a weight loss diet and supervised exercise, on reducing sleep apnea in older adults, and 2) determine whether this intervention is effective at improving parameters that are common to both sleep apnea and frailty, such as poor physical functional capacity and body composition, impaired or abnormal cardiometabolic function and increased levels of inflammation.

Interventions

BEHAVIORALLifestyle Intervention

Participants undergo 3 months of monitored exercise, consisting of aerobic and resistance training (3 days per week for 1 hour). Participants will also meet with a registered dietician, who will prescribe an American Heart Association low fat diet. The goal is to achieve a 1-2 lb weight loss per week.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* aged 60-75 * BMI between 30-42 * Apnea-Hypopnea Index above 10 events per hour (verified at baseline testing)

Exclusion criteria

* currently following a weight loss diet * history of substance abuse * participating in moderate to vigorous activity most days of the week * history of cardiovascular disease * currently being treated for sleep apnea * current cigarette smoking

Design outcomes

Primary

MeasureTime frameDescription
PolysomnographyBaseline and 3 monthsOvernight Polysomnography will be used to measure Apnea-hypopnea index (AHI)- The number of arousals occurring over the course of the night

Secondary

MeasureTime frameDescription
Vascular ReactivityBaseline and 3 monthsThe Endo-PAT2000 measures endothelium-mediated changes in vascular tone using biosensors that are attached to the fingertips
maximal oxygen uptakeBaseline and 3 monthsTesting is done on a treadmill. Participants will be asked to exercise to volitional fatigue
Body composition assessmentBaseline and 3 monthsParticipants will undergo Dual Energy X-ray Absorptiometry to evaluate total and regional body composition.
Muscle StrengthBaseline and 3 monthsStrength testing of the thigh will be done using an isokinetic dynamometer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026